ArticleBritish journal of clinical pharmacology2017

Optimizing the dose in cancer patients treated with imatinib, sunitinib and pazopanib.

Nienke A G Lankheet et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.